Diagnostic and prognostic morphometric features in WHO2003 invasive endometrial stromal tumours
- 26 March 2013
- journal article
- Published by Wiley in Histopathology
- Vol. 62 (5) , 688-694
Abstract
The aim of this study was to determine the value of morphometric features in distinguishing mild and moderate atypia and predicting the recurrence of World Health Organization 2003-defined endometrial stromal sarcoma and highly malignant undifferentiated endometrial sarcoma. Nuclear and cytological size, shape and arrangement were morphometrically evaluated in 41 cases with consensus no/mild (n = 38) or moderate (n = 3) atypia. None of the cases showed necrosis. The prognostic value of these features in predicting recurrence was also assessed. Seven features differed. The mean and standard deviation of the nuclear volume and the distance between the nuclei were the best discriminators between the no/mild and moderate atypia, with the maximum of the nuclear volume being a practically and rapidly evaluable alternative. With the use of these features, all mild and moderate atypias were correctly classified. Seven cases recurred. The distance between the nuclei and the percentage of nuclei with one neighbour (assessed with morphometric minimum spanning tree analysis) predicted recurrence. In invasive endometrial stromal tumours, morphometric features are useful diagnostic support tools for distinguishing mild from moderate atypia and predicting recurrence.Keywords
This publication has 10 references indexed in Scilit:
- Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patientsHistopathology, 2009
- FIGO staging for uterine sarcomasInternational Journal of Gynecology & Obstetrics, 2009
- Effects of rearrangement and allelic exclusion of JJAZ1 / SUZ12 on cell proliferation and survivalProceedings of the National Academy of Sciences, 2007
- Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of ageLaboratory Investigation, 2007
- Transition of endometrial stromal sarcoma into high-grade sarcomaGynecologic Oncology, 2006
- MIB1 as a possible predictor of recurrence in low-grade endometrial stromal sarcoma of the uterusGynecologic Oncology, 2003
- Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumorsProceedings of the National Academy of Sciences, 2001
- Quantitative Prognostic Features in FIGO I Ovarian Cancer Patients without Postoperative TreatmentGynecologic Oncology, 1998
- Value of quantitative pathological variables as prognostic factors in advanced ovarian carcinoma.Journal of Clinical Pathology, 1996
- Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumorsCancer, 1966